An Duy Tran

Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial.

Trisha Peel, Sarah Astbury, Allen C Cheng, David Paterson, Kirsty Buising, Tim Spelman, An Tran-Duy, Richard S de Steiger, undefined ASAP Trial Group

Journal article  |  2019  |  BMJ Open

INTRODUCTION: Resistant Gram-positive organisms, such as methicillin-resistant staphylococci, account for a significant proportion..

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood

Seamus Kent, Frauke Becker, Talitha Feenstra, Tran-Duy An, Iryna Schlackow, Michelle Tew, Ping Zhang, Wen Ye, Lizheng Shi, William Herman, Phil McEwan, Wendelin Schramm, Alastair Gray, Jose Leal, Mark Lamotte, Michael Willis, Andrew J Palmer, Philip Clarke

Journal article  |  2019  |  PharmacoEconomics

Transparency in health economic decision modelling is important for engendering confidence in the models and in the reliability of..

Chewing gum to treat postoperative nausea and emesis in female patients (CHEWY): rationale and design for a multicentre randomised trial

Jai Darvall, Britta Sylvia von Ungern-Sternberg, Sabine Braat, David Story, Andrew Davidson, Megan Allen, Tran-Duy An, Dana Middleton, Kate Leslie

Journal article  |  2019  |  BMJ Open

MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

A Tran-Duy, J Knight, AJ Palmer, B Eliasson, AM Svensson, PM Clarke

Conference Proceedings  |  2019  |  Value in Health

IMPACT OF COMORBID CONDITIONS ON HEALTH CARE EXPENDITURE AND WORK-RELATED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS USING THE MEDICAL EXPENDITURE PANEL SURVEY IN THE PERIOD 2006-2015

MV Vu, N Carvalho, R Buchbinder, G McColl, PM Clarke, A Tran-Duy

Conference Proceedings  |  2019  |  Value in Health

Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.

An Tran-Duy, Robyn McDermott, Josh Knight, Xinyang Hua, Elizabeth LM Barr, Kerry Arabena, Andrew Palmer, Philip M Clarke

Journal article  |  2019  |  Heart, Lung and Circulation

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death for Indigenous Australians. There is widespread belief that..

Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study

A Tran-Duy, NJ Connell, FH Vanmolkot, PC Souverein, NJ de Wit, CDA Stehouwer, AW Hoes, F de Vries, A de Boer

Journal article  |  2019  |  Journal of Internal Medicine

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity Results From a Pragmatic Open-Label Trial

An Tran-Duy, Marjan Ghiti Moghadam, Martijn AH Oude Voshaar, Harald E Vonkeman, Annelies Boonen, Philip Clarke, Geoff McColl, Peter M ten Klooster, TR Zijlstra, Willem F Lems, N Riyazi, EN Griep, JMW Hazes, Robert Landewe, Hein J Bernelot Moens, Piet LCM van Riel, Mart AFJ van de Laar, TL Jansen

Journal article  |  2018  |  Arthritis and Rheumatology

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Andrew J Palmer, Lei Si, Michelle Tew, Xinyang Hua, Michael S Willis, Christian Asseburg, Phil McEwan, Jose Leal, Alastair Gray, Volker Foos, Mark Lamotte, Talitha Feenstra, Patrick J O'Connor, Michael Brandle, Harry J Smolen, James C Gahn, William J Valentine, Richard F Pollock, Penny Breeze, Alan Brennan, et al.

Journal article  |  2018  |  Value in Health

Longevity of outstanding sporting achievers: Mind versus muscle

An Tran-Duy, David C Smerdon, Philip M Clarke

Journal article  |  2018  |  PLOS ONE

Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort

Xinyang Hua, Robyn McDermott, Thomas Lung, Mark Wenitong, An Tran-Duy, Ming Li, Philip Clarke

Journal article  |  2017  |  European Journal of Preventive Cardiology

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis Reply

An Tran-Duy, Bart Spaetgens, Arno W Hoes, Niek J De Wit, Coen DA Stehouwer

Journal article  |  2017  |  Clinical Gastroenterology and Hepatology

Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis

An Tran-Duy, Bart Spaetgens, Arno W Hoes, Niek J de Wit, Coen DA Stehouwer

Journal article  |  2016  |  Clinical Gastroenterology and Hepatology

Construct validity of radiographs of the feet to assess joint damage in patients with gout

B Spaetgens, C van Durme, C Webers, A Tran-Duy, T Schoonbrood, A Boonen

Journal article  |  2016  |  The Journal of Rheumatology

Increased Eligibility for Attempting Treatment-Free Remission (TFR) with Frontline Nilotinib (NIL) vs Imatinib (IM) in Patients with Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia (CML): Results of a Stochastic Simulation Model

Francois-Xavier Mahon, An Tran-Duy, Raechelle G Ocampo, David Ray, Estella Mendelson, Aby Buchbinder, Pascal Edrich, Sonya J Snedecor, Giuseppe Saglio

Conference Proceedings  |  2015  |  BLOOD

Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis

An Tran-Duy, Thien TV Nguyen, Herbert Thijs, Xenofon Baraliakos, Frank Heldmann, Juergen Braun, Annelies Boonen

Journal article  |  2015  |  Arthritis Care & Research

IMPLEMENTATION OF POPULATION DYNAMICS IN MODELLING HEALTH AND BUDGET IMPACT OF AN INTERVENTION FOR A CHRONIC DISEASE WITH MULTIPLE DISEASE SUBTYPES

A Tran-Duy, A Boonen, JJ Carol, JL Severens

Journal article  |  2015  |  Value in Health

CO-ADMINISTRATION OF PROTON PUMP INHIBITORS IN CHRONIC ASPIRIN USERS AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDY

A Tran-Duy, FH Vanmolkot, PC Souverein, AW Hoes, A de Boer, CD Stehower, NJ de Wit, MA Joore, F de Vries

Journal article  |  2015  |  Value in Health

Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-alpha antagonists in management of ankylosing spondylitis: a dynamic population modelling study

An Tran-Duy, Annelies Boonen, Mart AFJ van de Laar, Johan L Severens

Journal article  |  2015  |  Cost Effectiveness and Resource Allocation

Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis

A Tran-Duy, FH Vanmolkot, MA Joore, AW Hoes, CDA Stehouwer

Journal article  |  2015  |  International Journal of Clinical Practice

Health and Utilities in Patients With Gout Under the Care of a Rheumatologist

B Spaetgens, A Tran-Duy, JMA Wijnands, S van der Linden, A Boonen

Journal article  |  2015  |  Arthritis Care & Research

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment

Ron LH Handels, Manuela A Joore, An Tran-Duy, Anders Wimo, Claire AG Wolfs, Frans RJ Verhey, Johan L Severens

Journal article  |  2015  |  Alzheimer's & Dementia

Modelling Outcomes of Complex Treatment Strategies Following a Clinical Guideline for Treatment Decisions in Patients with Rheumatoid Arthritis

An Tran-Duy, Annelies Boonen, Wietske Kievit, Piet LCM van Riel, Mart AFJ van de Laar, Johan L Severens

Journal article  |  2014  |  PharmacoEconomics

How to Select the Right Cost-Effectiveness Model?

HGM van Haalen, JL Severens, A Tran-Duy, A Boonen

Journal article  |  2014  |  PharmacoEconomics

HOW TO SELECT THE RIGHT COST-EFFECTIVENESS MODEL? A SYSTEMATIC REVIEW AND STEPWISE APPROACH FOR TRANSFERRING AN EXISTING HEALTH ECONOMIC MODEL FOR RHEUMATOID ARTHRITIS

HGM van Haalen, A Tran-Duy, A Boonen, JL Severens

Conference Proceedings  |  2013  |  Value in Health

Presenteeism Predicts Sick Leave Better Than Basdai and/Or BASFI In A Longitudinal Cohort Of Patients With Ankylosing Spondylitis (EASIC)

Thi Vinh Nguyen Thien, An Tran-Duy, Frank Heldmann, Juergen Braun, Herbert Thijs, Annelies Boonen

Conference Proceedings  |  2013  |  ARTHRITIS AND RHEUMATISM

Comparison Of The Cost-Effectiveness Of The Treatment Strategies With and Without Biological Response Modifiers For Patients With Recently Diagnosed Rheumatoid Arthritis Following A Clinical Guideline For Treatment Selection

An Tran-Duy, Annelies Boonen, Wietske Kievit, Piet LCM van Riel, Mart AFJ van de laar, Johan L Severens

Conference Proceedings  |  2013  |  ARTHRITIS AND RHEUMATISM

SIMULTANEOUSLY MODELLING HEALTH IMPACT, BUDGET IMPACT AND COST-EFFECTIVENESS IN THE CONTEXT OF POPULATION DYNAMICS: THE CASE OF TUMOUR NECROSIS FACTOR-ALPHA ANTAGONIST FOR ANKYLOSING SPONDYLITIS IN THE DUTCH SOCIETY

A Tran-Duy, A Boonen, MAFJ van de Laar, JL Severens

Conference Proceedings  |  2012  |  CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

A discrete event modelling framework for simulation of long-term outcomes of sequential treatment strategies for ankylosing spondylitis

An Tran-Duy, Annelies Boonen, Mart AFJ van de Laar, Angelinus C Franke, Johan L Severens

Journal article  |  2011  |  Annals of the Rheumatic Diseases

COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR ANKYLOSING SPONDYLITIS: FIRST RESULTS OF A DISCRETE EVENT SIMULATION MODEL

Duy A Tran, A Boonen, J Arsenijevic, JL Severens

Conference Proceedings  |  2010  |  Value in Health